@ACSChemNeurosci profile picture
ACSChemNeurosci @ACSChemNeurosci

This account is no longer active or monitored. For updates about ACS Chemical Neuroscience, follow @ACSPublications and @ACSBioMed.

Joined August 2009
  • Tweets 2,067
  • Following 648
  • Followers 3,723
321 Photos and videos
Pinned Tweet
ACSChemNeurosci@ACSChemNeurosci
18 Jan 2025
This account will no longer be active or monitored. We welcome our community to follow @ACSPublications or sign up for e-Alerts for future updates from ACS Chemical Neuroscience: go.acs.org/cbL
1
294
Don't miss out on this exciting discussion! This collection from #ACSChemNeuro dives into the research around #MDMA as a potential breakthrough therapy Read the latest research ➡ go.acs.org/bMR
311
ACSChemNeurosci retweeted
ACS Publications@ACSPublications
15 Nov 2024
Next week is World #AntimicrobialResistance Awareness Week! Join us for a webinar discussing the cutting edge work being done to fight multi-drug resistant bacteria. 🦠 📅 Wed Nov 20, 11am EST. Register here ➡️ go.acs.org/bF7
Free Live Webinar Wednesday, November 20th, 2024, 11 am-12:30 pm EST New Targets, New Tools: Advancing the Fight Against Antimicrobial Resistance Co-produced with ACS Publications

ALT Free Live Webinar Wednesday, November 20th, 2024, 11 am-12:30 pm EST New Targets, New Tools: Advancing the Fight Against Antimicrobial Resistance Co-produced with ACS Publications
8
14
1,907
ACSChemNeurosci retweeted
Ketul Patel (Ph.D.)@ketspatel10
9 Oct 2024
Check out our recent works on Chronic pain published @ACSChemNeurosci A great collaboration between @DarrenDerksen lab and @zymedyne Many thanks to @MitacsCanada for the funding!
This tweet is unavailable
1
10
773
Don't miss out on this exciting discussion! This collection from #ACSChemNeuro dives into the research around #MDMA as a potential breakthrough therapy Read the latest research ➡ go.acs.org/auk
1
156
Curious about the latest research on MDMA treatments? Check out our recent collection of articles on the subject ➡ go.acs.org/arI
NYT Health
@NYTHealth
12 Aug 2024
The psychedelic treatment, for PTSD, was rejected last week by government regulators. nyti.ms/3YJoO4i
242
ACSChemNeurosci retweeted
ACS Publications Bio & Med Chem Content@ACSBioMed
29 Jul 2024
❗ LAST CALL! Call for Papers: ACS Pharmacology and Translational Science invites submissions for a Virtual Special Issue on new perspectives and advances in translational #pain research to treat pain. Submit papers by August 1, 2024 ➡ go.acs.org/ajc
1
4
463
ACSChemNeurosci retweeted
Mayke Alencar@MaykeAlencar
15 Jul 2024
I am proud to have collaborated with @cahhcardi et al in this amazing paper now published in @ACSChemNeurosci. Link: pubs.acs.org/doi/10.1021/acs… @Ariel_Lab
2
5
572
📢Stay up to date with the latest📢 This new collection of #ACSChemNeuro research joins the discussion around #MDMA as a potential breakthrough therapy Read the latest research ➡ go.acs.org/a9I
1
162
📢Stay up to date with the latest📢 This new collection of #ACSChemNeuro research joins the discussion around #MDMA as a potential breakthrough therapy Read the latest research ➡ go.acs.org/9Ze
1
135
ACSChemNeurosci retweeted
Aditya singh@Aditya_singh97
21 Jun 2024
Read our latest review on the gut-microbiome brain axis in Parkinson’s disease and role of “biotics” approach #neuroscience #gutmicrobiota @ACSChemNeurosci pubs.acs.org/doi/10.1021/acs…

Unveiling the Journey from the Gut to the Brain: Decoding Neurodegeneration–Gut Connection in...

Parkinson’s disease, a classical motor disorder affecting the dopaminergic system of the brain, has been as a disease of the brain, but this classical notion has now been viewed differently as the...

pubs.acs.org
1
4
246
📢Stay up to date with the latest📢 This new collection of #ACSChemNeuro research joins the discussion around #MDMA as a potential breakthrough therapy Read the latest research ➡ go.acs.org/9Mn
2
4
702
ACSChemNeurosci retweeted
IOCB Prague
@IOCBPrague
27 Feb 2024
#research Parallel Metabolomics and Lipidomics of a PSMA/GCPII Deficient Mouse Model Reveal Alteration of NAAG Levels and Brain Lipid Composition (Friedecký, @konvalinka_jan) - @ACSChemNeurosci: doi.org/10.1021/acschemneuro… @FriedeckyGroup @IOCBPrague @CzechAcademy @UPOlomouc

Parallel Metabolomics and Lipidomics of a PSMA/GCPII Deficient Mouse Model Reveal Alteration of...

Glutamate carboxypeptidase II (GCPII, also known as PSMA or FOLH1) is responsible for the cleavage of N-acetyl-aspartyl-glutamate (NAAG) to N-acetyl-aspartate and glutamate in the central nervous...

pubs.acs.org
4
10
2,826
ACSChemNeurosci retweeted
Jacob Bell@realJacobBell
4 Jun 2024
To sum up today's adcomm: While the experts saw potential in the use of MDMA-assisted therapy in the treatment of PTSD, there were too many confounding variables and possible safety concerns to push for approval #Lykos
2
1
2
390
FDA Advisory Committee votes against recommending Lykos' #MDMA treatment for PTSD Read our latest MDMA research here ➡ go.acs.org/9Er
2
3
884
Fascinating discussions online today surrounding the FDA's consideration of a new #MDMA treatment for PTSD 🤔 When is a double-blinded study not enough? How can you blind for a treatment that includes such pronounced and well-known effects? Let us know what you think! ⬇
1
4
4
1,473
@jmhooker @zenbrainest want to kick off the discussion?
1
567
📢New collection of #ACSChemNeuro research as the FDA is expected to announce a decision on a new treatment involving #MDMA today ⏰ Read the latest research ➡ go.acs.org/9Er
4
6
1,215
ACSChemNeurosci retweeted
Eric Sparkes@eric_sparkes
24 May 2024
It's all things adamantane in our (@Lambert_Usyd) latest synthetic cannabinoid work, out now in @ACSChemNeurosci! We synthesised and evaluated a library of adamantane-derived SCRAs, including fluorinated and deuterated analogues 🧪 🧵 pubs.acs.org/doi/10.1021/acs…

Structure–Activity Relationships, Deuteration, and Fluorination of Synthetic Cannabinoid Receptor...

Synthetic cannabinoid receptor agonists (SCRAs) are a growing class of new psychoactive substances (NPS) commonly derived from an N-alkylated indole, indazole, or 7-azaindole scaffold. Diversificat...

pubs.acs.org
1
3
13
1,255
ACSChemNeurosci retweeted
Alex Kwan 關進晞@kwanalexc
27 May 2024
This study builds on our @ACSChemNeurosci paper last year, where @PashaDavoudian mapped c-Fos response in the brain after psilocybin or ketamine, identifying the list of shared and distinct brain regions impacted by the drugs pubs.acs.org/doi/10.1021/acs…

Shared and Distinct Brain Regions Targeted for Immediate Early Gene Expression by Ketamine and...

Psilocybin is a psychedelic with therapeutic potential. While there is growing evidence that psilocybin exerts its beneficial effects through enhancing neural plasticity, the exact brain regions...

pubs.acs.org
1
2
6
792
Load more